...
首页> 外文期刊>Cancer Cell International >Molecular mechanism of G 1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
【24h】

Molecular mechanism of G 1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells

机译:新型CDK4 / CDK6抑制剂LEE011诱导白血病细胞G 1阻滞和细胞衰老的分子机制

获取原文
           

摘要

Background Overexpression of cyclin D1 dependent kinases 4 and 6 (CDK4/6) is a common feature of many human cancers including leukemia. LEE011 is a novel inhibitor of both CDK4 and 6. To date, the molecular function of LEE011 in leukemia remains unclear. Methods Leukemia cell growth and apoptosis following LEE011 treatment was assessed through CCK-8 and annexin V/propidium iodide staining assays. Cell senescence was assessed by β-galactosidase staining and p16INK4a expression analysis. Gene expression profiles of LEE011 treated HL-60 cells were investigated using an Arraystar Human LncRNA array. Gene ontology and KEGG pathway analysis were then used to analyze the differentially expressed genes from the cluster analysis. Results Our studies demonstrated that LEE011 inhibited proliferation of leukemia cells and could induce apoptosis. Hoechst 33,342 staining analysis showed DNA fragmentation and distortion of nuclear structures following LEE011 treatment. Cell cycle analysis showed LEE011 significantly induced cell cycle G1 arrest in seven of eight acute leukemia cells lines, the exception being THP-1 cells. β-Galactosidase staining analysis and p16INK4a expression analysis showed that LEE011 treatment can induce cell senescence of leukemia cells. LncRNA microarray analysis showed 2083 differentially expressed mRNAs and 3224 differentially expressed lncRNAs in LEE011-treated HL-60 cells compared with controls. Molecular function analysis showed that LEE011 induced senescence in leukemia cells partially through downregulation of the transcriptional expression of MYBL2. Conclusions We demonstrate for the first time that LEE011 treatment results in inhibition of cell proliferation and induction of G1 arrest and cellular senescence in leukemia cells. LncRNA microarray analysis showed differentially expressed mRNAs and lncRNAs in LEE011-treated HL-60 cells and we demonstrated that LEE011 induces cellular senescence partially through downregulation of the expression of MYBL2. These results may open new lines of investigation regarding the molecular mechanism of LEE011 induced cellular senescence.
机译:背景细胞周期蛋白D1依赖性激酶4和6(CDK4 / 6)的过表达是许多人类癌症(包括白血病)的普遍特征。 LEE011是CDK4和6的新型抑制剂。迄今为止,尚不清楚LEE011在白血病中的分子功能。方法通过CCK-8和膜联蛋白V /碘化丙锭染色法评估LEE011治疗后的白血病细胞生长和凋亡。通过β-半乳糖苷酶染色和p16 INK4a 表达分析来评估细胞的衰老。使用Arraystar Human LncRNA阵列研究LEE011处理的HL-60细胞的基因表达谱。然后使用基因本体论和KEGG通路分析法从聚类分析中分析差异表达的基因。结果我们的研究表明,LEE011可抑制白血病细胞的增殖并诱导凋亡。 Hoechst 33,342染色分析显示,经过LEE011处理后,DNA断裂并破坏了核结构。细胞周期分析显示,LEE​​011显着诱导了八种急性白血病细胞系中七种的细胞周期G 1 阻滞,THP-1细胞除外。 β-半乳糖苷酶染色分析和p16 INK4a 表达分析表明,LEE011处理可诱导白血病细胞衰老。 LncRNA微阵列分析显示,与对照组相比,LEE011处理的HL-60细胞中有2083个差异表达的mRNA和3224个差异表达的lncRNA。分子功能分析表明,LEE011部分通过下调MYBL2转录表达来诱导白血病细胞衰老。结论我们首次证明LEE011治疗可抑制白血病细胞的细胞增殖,诱导G 1 阻滞和细胞衰老。 LncRNA芯片分析显示在LEE011处理的HL-60细胞中差异表达的mRNA和lncRNA,并且我们证明LEE011部分通过下调MYBL2的表达诱导细胞衰老。这些结果可能开辟有关LEE011诱导细胞衰老的分子机制的新研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号